Table 1.

Conditions for in vivo tumorigenesis.

Group	Mouse Strain	Treatment	Dose	Dosing volume	Dosing route	Schedule
Immunocompetent	C57BL/6 J	Rat IgG2a/b	2.5 mpk for each IgG	10 μL/g	i.p.	Every other day
Immunotherapy	C57BL/6 J	Anti-PD-1	5 mpk	10 μL/g	i.p.	Every other day
Immunotherapy	C57BL/6 J	Anti-PD-L1	5 mpk	10 μL/g	i.p.	Every other day
Immunodeficient	C57BL/6 J	Anti-CD4/CD8	500 μg	10 μL/g	i.p.	Every week
Immunodeficient	Nude	Rat IgG2a/b	2.5 mpk	10 μL/g	i.p.	Every other day